Medicines and Healthcare products Regulatory Agency
| 1: Authorisation Number | UK MIA(IMP) 54923 | 
|---|---|
| 2: Name of authorisation holder | ADVENT BIOSERVICES LTD | 
| 3: Address(es) of manufacturing site(s) | ADVENT BIOSERVICES LTD, SAWSTON BUSINESS PARK, SAWSTON, CAMBRIDGE, CB22 3JG, UNITED KINGDOM | 
| 4: Legally registered address of authorisation holder | ADVENT BIOSERVICES LTD, SAWSTON BUSINESS PARK, SAWSTON, CAMBRIDGE, CB22 3JG, UNITED KINGDOM | 
| 5: Scope of authorisation and dosage forms | ANNEX 1 and/ or ANNEX 2 | 
| 6: Legal Basis of authorisation | |
| 7: Name of responsible officer of the competent authority of the member state granting the manufacturing authorisation | Confidential | 
| 8: Authorisation Date | 21/08/2025 | 
| 9: Annexes attached | Annex 1 and/or Annex 2 | 
SCOPE OF AUTHORISATION
        Annex 2
        
          Name and address of the site: 
          
      
              
          
  
        
        
        ADVENT BIOSERVICES LTD, SAWSTON BUSINESS PARK, SAWSTON, CAMBRIDGE, CB22 3JG, UNITED KINGDOM
                                          Human Investigational Medicinal Products
                  
      | Authorised Operations | 
| MANUFACTURING OPERATIONS (according to part 1)IMPORTATION OF MEDICINAL PRODUCTS (according to part 2) | 
| Part 1 - MANUFACTURING OPERATIONS | 
| [ 1.1 ] Sterile Investigational Medicinal Products | 
| [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) | 
| [ 1.1.1.6 ] Other aseptically prepared products Cellular therapy products | 
| [ 1.1.3 ] Batch certification | 
| [ 1.3 ] Biological investigational medicinal products | 
| [ 1.3.1 ] Biological medicinal products | 
| [ 1.3.1.3 ] Cell therapy products Special Requirements Live Cells | 
| [ 1.3.2 ] Batch certification | 
| [ 1.3.2.3 ] Cell therapy products Special Requirements Live Cells | 
| [ 1.5 ] Packaging | 
| [ 1.5.2 ] Secondary packaging | 
| [ 1.6 ] Quality control testing | 
| [ 1.6.1 ] Microbiological: sterility | 
| [ 1.6.2 ] Microbiological: non-sterility | 
| [ 1.6.4 ] Biological | 
| Part 2 - IMPORTATION OF MEDICINAL PRODUCTS | 
| [ 1.1 ] Sterile Investigational Medicinal Products | 
| [ 1.1.1 ] Aseptically prepared (processing operations for the following dosage forms) | 
| [ 1.1.1.6 ] Other aseptically prepared products Cellular therapy products | 
| [ 1.1.3 ] Batch certification | 
| [ 1.3 ] Biological investigational medicinal products | 
| [ 1.3.1 ] Biological medicinal products | 
| [ 1.3.1.3 ] Cell therapy products Special Requirements Live Cells | 
| [ 1.3.2 ] Batch certification | 
| [ 1.3.2.3 ] Cell therapy products Special Requirements Live Cells | 
| [ 1.5 ] Packaging | 
| [ 1.5.2 ] Secondary packaging | 
| [ 1.6 ] Quality control testing | 
| [ 1.6.1 ] Microbiological: sterility | 
| [ 1.6.2 ] Microbiological: non-sterility | 
| [ 1.6.4 ] Biological | 
| [ 2.3 ] Other Importation Activities | 
| [ 2.3.4 ] Other Importation of QP-certified IMPs from a country on the approved country for import list | 
